Camptosar
Active Ingredient(s): IrinotecanFDA Approved: * June 14, 1996
Pharm Company: * PHARMACIA AND UPJOHN
Category: Cancer
Irinotecan, sold under the brand name Camptosar among others, is a medication used to treat colon cancer, and small cell lung cancer.[4] For colon cancer it is used either alone or with fluorouracil.[4] For small cell lung cancer it is used with cisplatin.[4] It is given intravenously.[4] Common side effects include diarrhea, vomiting, bone marrow suppression, hair loss, shortness of breath, and fever.[4] Other se... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.1 Discussion